A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cryptenamine
Urapidil
The risk or severity of adverse effects can be increased when Desipramine is combined with Urapidil.
Cryptenamine
Ketanserin
The risk or severity of adverse effects can be increased when Desipramine is combined with Ketanserin.
Cryptenamine
Orvepitant
The risk or severity of adverse effects can be increased when Desipramine is combined with Orvepitant.
Cryptenamine
Esreboxetine
The risk or severity of adverse effects can be increased when Desipramine is combined with Esreboxetine.
Cryptenamine
Piclozotan
The risk or severity of adverse effects can be increased when Desipramine is combined with Piclozotan.
Cryptenamine
Cerlapirdine
The risk or severity of adverse effects can be increased when Desipramine is combined with Cerlapirdine.
Cryptenamine
Eplivanserin
The risk or severity of adverse effects can be increased when Desipramine is combined with Eplivanserin.
Cryptenamine
Sarpogrelate
The risk or severity of adverse effects can be increased when Desipramine is combined with Sarpogrelate.
Cryptenamine
MK-212
The risk or severity of adverse effects can be increased when Desipramine is combined with MK-212.
Cryptenamine
m-Chlorophenylpiperazine
The risk or severity of adverse effects can be increased when Desipramine is combined with m-Chlorophenylpiperazine.
Cryptenamine
Vabicaserin
The risk or severity of adverse effects can be increased when Desipramine is combined with Vabicaserin.
Cryptenamine
Idalopirdine
The risk or severity of adverse effects can be increased when Desipramine is combined with Idalopirdine.
Cryptenamine
Lanicemine
The risk or severity of adverse effects can be increased when Desipramine is combined with Lanicemine.
Cryptenamine
Tetrahydrocannabivarin
The risk or severity of adverse effects can be increased when Desipramine is combined with Tetrahydrocannabivarin.
Cryptenamine
Iferanserin
The risk or severity of adverse effects can be increased when Desipramine is combined with Iferanserin.
Cryptenamine
Mosapride
The risk or severity of adverse effects can be increased when Desipramine is combined with Mosapride.
Cryptenamine
Iproclozide
The risk or severity of adverse effects can be increased when Desipramine is combined with Iproclozide.
Cryptenamine
Talopram
The risk or severity of adverse effects can be increased when Desipramine is combined with Talopram.
Cryptenamine
Lortalamine
The risk or severity of adverse effects can be increased when Desipramine is combined with Lortalamine.
Cryptenamine
Nisoxetine
The risk or severity of adverse effects can be increased when Desipramine is combined with Nisoxetine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3